Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Gaziano, Thomas A ^a,c   Pandya, Ankur ^b   Steyn, Krisela ^c   Levitt, Naomi ^c   Mollentze, Willie ^d   Joubert, Gina ^d   Walsh, Corinna M ^e   Motala, Ayesha A ^f   Kruger, Annamarie ^g   Schutte, Aletta E ^g   Naidoo, Datshana P ^h   Prakaschandra, Dorcas R ⁱ   Laubscher, Ria ^j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF THE FREE STATE   (South Africa)

^e CENTRAL UNIVERSITY OF TECHNOLOGY   (South Africa)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g NORTH WEST UNIVERSITY   (South Africa)

^h UNIVERSITY OF KWAZULU NATAL   (South Africa)

ⁱ DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^j SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

more..

Author keywords

Cardiovascular disease; Cholesterol; Coronary heart disease; Prevention; Stroke

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RISK ASSESSMENT; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK ASSESSMENT; SOUTH AFRICA;

EID: 84880377793     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-170     Document Type: Article

References (28)

1. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365:434-441.
2. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 2005, 112:3569-3576. 10.1161/CIRCULATIONAHA.105.535922, 16330698.
3. Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham heart study general cardiovascular risk profile. Circulation 2009, 120:384-390. 10.1161/CIRCULATIONAHA.108.835470, 19620502.
4. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003. 10.1016/S0195-668X(03)00114-3, 12788299, SCORE project group.
5. Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, Perola M, Peltonen L, Shields D, Tunstall-Pedoe H, Kuulasmaa K, MORGAM Project MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol 2005, 34:21-27. MORGAM Project.
6. Palmieri L, Donfrancesco C, Giampaoli S, Trojani M, Panico S, Vanuzzo D, Pilotto L, Cesana G, Ferrario M, Chiodini P, Sega R, Stamler J. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil 2006, 13:562-570. 10.1097/01.hjr.0000221866.27039.4b, 16874146.
7. Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Ferrario M, Chiodini P, Pilotto L, Donfrancesco C, Cesana G, Sega R, Stamler J. Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Am J Epidemiol 2006, 163:893-902. 10.1093/aje/kwj110, 16554350.
8. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008, 371:923-931. 10.1016/S0140-6736(08)60418-3, 2864150, 18342687.
9. Pandya A, Weinstein MC, Gaziano TA. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population. PLoS One 2011, 6:e20416. 10.1371/journal.pone.0020416, 3105026, 21655241.
10. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991, 121:293-298. 10.1016/0002-8703(91)90861-B, 1985385.
11. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
12. Giampaoli S, Palmieri L, Donfrancesco C, Panico S, Vanuzzo D, Pilotto L, Ferrario M, Cesana G, Mattiello A. Cardiovascular risk assessment in Italy: the CUORE project risk score and risk chart. Italian J Public Health 2007, 5:102-109.
13. Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?. Circulation 2010, 122:300-310. 10.1161/CIRCULATIONAHA.109.852756, 20644026.
14. Mollentze WF, Moore AJ, Steyn AF, Joubert G, Steyn K, Oosthuizen GM, Weich DJ. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995, 85:90-96.
15. Motala AA, Esterhuizen T, Gouws E, Pirie FJ, Omar MA. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008, 31:1783-1788. 10.2337/dc08-0212, 2518345, 18523142.
16. Rossouw JE, Jooste PL, Chalton DO, Jordaan ER, Langenhoven ML, Jordaan PC, Steyn M, Swanepoel AS, Rossouw LJ. Community-based intervention: the Coronary Risk Factor Study (CORIS). Int J Epidemiol 1993, 22:428-438. 10.1093/ije/22.3.428, 8359958.
17. Steyn K, Jooste PL, Bourne L, Fourie J, Badenhorst CJ, Bourne DE, Langenhoven ML, Lombard CJ, Truter H, Katzenellenbogen J, et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. The BRISK study. S Afr Med J 1991, 79:480-485.
18. Steyn K, Jooste PL, Langenhoven ML, Benade AJ, Rossouw JE, Steyn M, Jordaan PC, Parry CD. Coronary risk factors in the coloured population of the Cape Peninsula. S Afr Med J 1985, 67:619-625.
19. Steyn K, Levitt NS, Hoffman M, Marais AD, Fourie JM, Lambert EV, Gaziano TA, Kepe L, Lombard CJ. The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study. Ethn Dis 2004, 14:233-242.
20. Van Zyl S, van der Merwe LJ, Walsh CM, Groenewald AJ, Van Rooyen FC. Risk-factor profiles for chronic diseases of lifestyle and metabolic syndrome in an urban and rural setting in South Africa. Afr J Prm Health Care Fam Med 2012, 4:10.
21. Gaddis ML, Gaddis GM. Introduction to biostatistics: part 6, correlation and regression. Ann Emerg Med 1990, 19:1462-1468. 10.1016/S0196-0644(05)82622-8, 2240762.
22. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J, South African Demographic and Health Coordinating Team Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001, 19:1717-1725. 10.1097/00004872-200110000-00004, 11593090, South African Demographic and Health Coordinating Team.
23. World Health Organization WHO/ISH cardiovascular risk prediction charts 2007, Geneva, Switzerland: World Health Organization, World Health Organization.
24. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
25. Mukaka M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012, 24:69-71. 3576830, 23638278.
26. Management Sciences for Health, World Health Organization International Drug Price Indicator Guide 2009, Geneva, Switzerland: World Health Organization, 2009, Management Sciences for Health, World Health Organization.
27. Kruger A, Wissing MP, Towers GW, Doak CM. Sex differences independent of other psycho-sociodemographic factors as a predictor of body mass index in black South African adults. J Health Popul Nutr 2012, 30:56-65. 3312360, 22524120.
28. Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, Woodward M. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health 2007, 61:115-121. 2465638, 17234869.